Ethical considerations and management strategies for fertility preservation in women of reproductive age with malignant tumors: Chinese practices and perspectives - Top-Institutions - MDSpire

Ethical considerations and management strategies for fertility preservation in women of reproductive age with malignant tumors: Chinese practices and perspectives

  • By

  • Ke Wang

  • Shihui Wang

  • Jianjiang Gao

  • Jiahuan Zhang

  • Jianqing Zhu

  • May 25, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Moores Cancer Center
    Moores Cancer Center

    San Diego, California

    Key Differentiators

    • Oncology
    • Reproductive Medicine

  • #2

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology
    • Reproductive Medicine

  • #3

    University of California, San Diego
    University of California, San Diego

    La Jolla, California

    Key Differentiators

    • Oncology
    • Reproductive Medicine

  • #4

    Department of Obstetrics, Gynecology, and Reproductive Sciences
    Department of Obstetrics, Gynecology, and Reproductive Sciences

    San Francisco, California

    Key Differentiators

    • Obstetrics
    • Gynecology
    • Reproductive Medicine

  • #5

    Center for Obstetrics and Gynecology Research Innovations
    Center for Obstetrics and Gynecology Research Innovations

    New York, New York

    Key Differentiators

    • Obstetrics
    • Gynecology
    • Reproductive Medicine

Original Source(s)

Ethical considerations and management strategies for fertility preservation in women of reproductive age with malignant tumors: Chinese practices and perspectives

  • by Ke Wang, Shihui Wang, Jianjiang Gao, Jiahuan Zhang, Jianqing Zhu

  • May 25, 2026

Related Content

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry